Patents by Inventor Hans-Henrik Kristensen Hogenhaug

Hans-Henrik Kristensen Hogenhaug has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Antimicrobial polypeptides
    Patent number: 8080390
    Abstract: The present invention relates to polypeptides having antimicrobial activity and polynucleotides having a nucleotide sequence which encodes for the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the nucleic acid constructs as well as methods for producing and using the polypeptides.
    Type: Grant
    Filed: January 19, 2009
    Date of Patent: December 20, 2011
    Assignee: Novozymes Adenium Biotech A/S
    Inventors: Hans-Henrik Kristensen Hogenhaug, Per Holse Mygind, Dorotea Raventos Segura, Olivier Taboureau, Carsten Peter Sonksen
  • Recombinant production of antimicrobial peptides
    Patent number: 7935501
    Abstract: The invention relates to the use of co-expression of an antimicrobial agent and an enzyme, with a view to improving yield and/or overall production economy. Examples of antimicrobial agents are antimicrobial peptides such as lactoferricins and antimicrobial enzymes such as lysozyme and glucose oxidase, and examples of enzymes are endoglucanase, xylanase, phytase, protease, galactanase, mannanase, dextranase, alpha-galactosidase, pectate lyase, alpha-amylase and glucoamylase. A fusion product comprising the antimicrobial agent and the enzyme and a cleavable linker is novel, and can be used in animal feed and animal feed additives. The invention also describes the use of a protection domain wherein at least 50% of the amino acid residues comprised in the peptide protection domain are D (Asp) and/or E (Glu). The protection or quenching domain serves to temporarily and reversibly inactivate the antimicrobial peptide during the expression.
    Type: Grant
    Filed: September 13, 2004
    Date of Patent: May 3, 2011
    Assignee: Novozymes Pharma Biotec A/S
    Inventors: Ejner Bech Jensen, Hans-Henrik Kristensen Høgenhaug, Peter Kamp Hansen, Poul Erik Pedersen, Per Holse Mygind
  • USE OF DEFENSINS AGAINST TUBERCULOSIS
    Publication number: 20110053836
    Abstract: The present invention relates to a method for killing or inhibiting cells of Mycobacterium, in particular M. tuberculosis, with certain defensins.
    Type: Application
    Filed: November 2, 2010
    Publication date: March 3, 2011
    Applicant: NOVOZYMES ADENIUM BIOTECH A/S
    Inventors: HANS-HENRIK KRISTENSEN HOGENHAUG, GARY K. SCHOOLNIK, SIDHARTH CHOPRA, DOROTEA RAVENTOS SEGURA
  • Synthetic antimicrobial polypeptides
    Patent number: 7833967
    Abstract: The present invention relates to polypeptides having antimicrobial activity and polynucleotides having a nucleotide sequence which encodes for the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the nucleic acid constructs as well as methods for producing and using the polypeptides.
    Type: Grant
    Filed: June 21, 2007
    Date of Patent: November 16, 2010
    Assignee: Novozymesadenium BioTech A/S
    Inventor: Hans-Henrik Kristensen Hogenhaug
  • USE OF DEFENSINS AGAINST MENINGITIS
    Publication number: 20090253629
    Abstract: The present invention relates to methods for treating meningitis, such as bacterial meningitis, with defensin polypeptides.
    Type: Application
    Filed: March 31, 2009
    Publication date: October 8, 2009
    Applicant: Novozymes A/S
    Inventors: Dorthe Sandvang, Hans-Henrik Kristensen Hogenhaug
  • USE OF DEFENSINS AGAINST TUBERCULOSIS
    Publication number: 20090227506
    Abstract: The present invention relates to a method for killing or inhibiting cells of the genus Mycobacterium, in particular M. tuberculosis, with certain defensins.
    Type: Application
    Filed: March 4, 2009
    Publication date: September 10, 2009
    Applicant: Novozymes A/S
    Inventors: Hans-Henrik Kristensen Hogenhaug, Gary K. Schoolnik, Sidharth Chopra, Dorotea Raventos Segura
  • ANTIMICROBIAL POLYPEPTIDES
    Publication number: 20090137481
    Abstract: The present invention relates to polypeptides having antimicrobial activity and polynucleotides having a nucleotide sequence which encodes for the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the nucleic acid constructs as well as methods for producing and using the polypeptides.
    Type: Application
    Filed: January 19, 2009
    Publication date: May 28, 2009
    Applicant: Novozymes A/S
    Inventors: Hans-Henrik Kristensen Hogenhaug, Per Holse Mygind, Dorotea Raventos Segura, Olivier Taboureau, Carsten Peter Sonksen
  • Antimicrobial polypeptides
    Patent number: 7504375
    Abstract: The present invention relates to polypeptides having antimicrobial activity and polynucleotides having a nucleotide sequence which encodes for the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the nucleic acid constructs as well as methods for producing and using the polypeptides.
    Type: Grant
    Filed: August 22, 2006
    Date of Patent: March 17, 2009
    Assignee: Novozymes A/S
    Inventors: Hans-Henrik Kristensen Hogenhaug, Per Holse Mygind, Dorotea Raventos Segura, Olivier Taboureau, Carsten Peter Sonksen
  • Synthetic antimicrobial polypeptides
    Patent number: 7250398
    Abstract: The present invention relates to polypeptides having antimicrobial activity and polynucleotides having a nucleotide sequence which encodes for the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the nucleic acid constructs as well as methods for producing and using the polypeptides.
    Type: Grant
    Filed: January 6, 2005
    Date of Patent: July 31, 2007
    Assignee: Novozymes A/S
    Inventor: Hans-Henrik Kristensen Hogenhaug
  • Antimicrobial polypeptides
    Patent number: 7148404
    Abstract: The present invention relates to polypeptides having antimicrobial activity and polynucleotides having a nucleotide sequence which encodes for the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the nucleic acid constructs as well as methods for producing and using the polypeptides.
    Type: Grant
    Filed: May 2, 2005
    Date of Patent: December 12, 2006
    Assignee: Novozymes A/S
    Inventors: Hans-Henrik Kristensen Hogenhaug, Per Holse Mygind, Dorotea Raventos Segura, Olivier Taboureau, Carsten Peter Sonksen